Insider Trading activities of Editas Medicine, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Editas Medicine, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Editas Medicine, Inc. since year 2005. Table 2 shows the detailed insider transactions of Editas Medicine, Inc. since 2005. The reporting company's ticker symbol is EDIT. The reporting company's CIK number is 1650664.
The total value of stock buying since 2005 is $1,600,000.
The total value of stock sales since 2005 is $46,030,152.
The total value of stock option exercises since 2005 is $63,340.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Editas Medicine, Inc. (EDIT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-05 0 $0 1,000,000 $17,000,000 0 $0
2017-03 0 $0 1,000 $26,410 1,000 $650
2017-02 0 $0 9,000 $188,052 9,000 $13,590
2017-01 0 $0 15,000 $288,000 15,000 $48,450
2016-12 0 $0 410,000 $6,478,400 0 $0
2016-11 0 $0 308,058 $5,135,622 0 $0
2016-09 0 $0 1,005,890 $16,893,668 0 $0
2016-08 0 $0 1,000 $20,000 1,000 $650
2016-02 100,000 $1,600,000 0 $0 0 $0
2015-02 4,081,628 $0 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Editas Medicine, Inc. insiders (EDIT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-05-22 Bitterman Kevin (Director) Sale 1,000,000 17.00 17,000,000
2017-03-15 Glucksmann Alexandra (Chief Operating Officer) Sale 1,000 26.41 26,410
2017-03-15 Glucksmann Alexandra (Chief Operating Officer) Option Ex 1,000 .65 650
2017-02-15 Glucksmann Alexandra (Chief Operating Officer) Sale 6,000 21.74 130,452
2017-02-15 Glucksmann Alexandra (Chief Operating Officer) Option Ex 6,000 .65 3,900
2017-02-15 Hack Andrew A. F. (Chief Financial Officer) Sale 3,000 19.20 57,600
2017-02-15 Hack Andrew A. F. (Chief Financial Officer) Option Ex 3,000 3.23 9,690
2017-01-11 Hack Andrew A. F. (Chief Financial Officer) Sale 15,000 19.20 288,000
2017-01-11 Hack Andrew A. F. (Chief Financial Officer) Option Ex 15,000 3.23 48,450
2016-12-07 Bitterman Kevin (Director) Sale 75,000 15.82 1,186,500
2016-12-07 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 75,000 15.82 1,186,500
2016-12-06 Bitterman Kevin (Director) Sale 50,000 15.87 793,500
2016-12-06 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 50,000 15.87 793,500
2016-12-05 Bitterman Kevin (Director) Sale 80,000 15.74 1,259,200
2016-12-05 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 80,000 15.74 1,259,200
2016-11-23 Bitterman Kevin (Director) Sale 21,480 15.71 337,450
2016-11-23 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 21,480 15.71 337,450
2016-11-22 Bitterman Kevin (Director) Sale 12,819 15.77 202,155
2016-11-22 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 12,819 15.77 202,155
2016-11-16 Bitterman Kevin (Director) Sale 30,830 16.30 502,529
2016-11-16 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 30,830 16.30 502,529
2016-11-15 Bitterman Kevin (Director) Sale 30,865 17.16 529,797
2016-11-15 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 30,865 17.16 529,797
2016-11-14 Bitterman Kevin (Director) Sale 58,035 17.16 995,880
2016-11-14 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 58,035 17.16 995,880
2016-09-08 Bitterman Kevin (Director) Sale 500,000 16.80 8,400,000
2016-09-08 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 500,000 16.80 8,400,000
2016-09-06 Starr Kevin P (10% Owner) Sale 5,890 15.90 93,668
2016-08-23 Glucksmann Alexandra (Chief Operating Officer) Sale 1,000 20.00 20,000
2016-08-23 Glucksmann Alexandra (Chief Operating Officer) Option Ex 1,000 .65 650
2016-02-08 Deerfield Mgmt Hif, L.p. Buy 100,000 16.00 1,600,000
2015-02-08 Viking Long Fund Master Ltd. Buy 2,040,814 .00 0
2015-02-08 Sundheim Daniel S. Buy 2,040,814 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of EDIT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Editas Medicine, Inc. (symbol EDIT, CIK number 1650664) see the Securities and Exchange Commission (SEC) website.